A detailed history of D.A. Davidson & Co. transactions in Boston Scientific Corp stock. As of the latest transaction made, D.A. Davidson & Co. holds 10,945 shares of BSX stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,945
Previous 10,603 3.23%
Holding current value
$1.1 Million
Previous $816,000 12.38%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $24,952 - $28,728
342 Added 3.23%
10,945 $917,000
Q2 2024

Jul 31, 2024

BUY
$67.33 - $77.71 $12,388 - $14,298
184 Added 1.77%
10,603 $816,000
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $59,846 - $71,296
1,039 Added 11.08%
10,419 $713,000
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $25,730 - $30,581
529 Added 5.98%
9,380 $542,000
Q3 2023

Nov 08, 2023

BUY
$50.19 - $54.68 $15,609 - $17,005
311 Added 3.64%
8,851 $467,000
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $5,518 - $6,065
111 Added 1.32%
8,540 $461,000
Q1 2023

Apr 25, 2023

SELL
$45.09 - $50.03 $63,126 - $70,042
-1,400 Reduced 14.24%
8,429 $421,000
Q4 2022

Feb 03, 2023

SELL
$39.56 - $47.22 $14,676 - $17,518
-371 Reduced 3.64%
9,829 $454,000
Q3 2022

Nov 07, 2022

BUY
$36.71 - $109.66 $6,277 - $18,751
171 Added 1.71%
10,200 $395,000
Q2 2022

Jul 28, 2022

BUY
$35.24 - $47.1 $58,674 - $78,421
1,665 Added 19.91%
10,029 $374,000
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $2,454 - $2,706
60 Added 0.72%
8,364 $370,000
Q4 2021

Jan 31, 2022

BUY
$38.07 - $44.87 $5,824 - $6,865
153 Added 1.88%
8,304 $353,000
Q2 2021

Aug 10, 2021

SELL
$38.58 - $44.24 $9,259 - $10,617
-240 Reduced 2.86%
8,151 $349,000
Q1 2021

May 07, 2021

BUY
$35.27 - $39.67 $19,398 - $21,818
550 Added 7.01%
8,391 $324,000
Q4 2020

Feb 10, 2021

SELL
$33.15 - $41.97 $1.14 Million - $1.44 Million
-34,360 Reduced 81.42%
7,841 $282,000
Q3 2020

Nov 02, 2020

BUY
$34.44 - $42.23 $482,745 - $591,937
14,017 Added 49.73%
42,201 $1.61 Million
Q2 2020

Aug 10, 2020

BUY
$30.19 - $39.11 $185,819 - $240,722
6,155 Added 27.94%
28,184 $990,000
Q1 2020

May 05, 2020

BUY
$25.83 - $45.71 $55,482 - $98,185
2,148 Added 10.8%
22,029 $719,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $16,549 - $19,826
437 Added 2.25%
19,881 $899,000
Q3 2019

Nov 05, 2019

SELL
$40.31 - $43.45 $54,337 - $58,570
-1,348 Reduced 6.48%
19,444 $791,000
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $69,785 - $85,917
-1,999 Reduced 8.77%
20,792 $894,000
Q1 2019

May 13, 2019

SELL
$32.91 - $40.75 $6,713 - $8,313
-204 Reduced 0.89%
22,791 $823,000
Q4 2018

Jan 29, 2019

SELL
$31.73 - $39.04 $67,489 - $83,038
-2,127 Reduced 8.47%
22,995 $813,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $43,499 - $51,184
1,325 Added 5.57%
25,122 $967,000
Q2 2018

Aug 02, 2018

BUY
$26.84 - $34.32 $12,292 - $15,718
458 Added 1.96%
23,797 $778,000
Q1 2018

May 04, 2018

SELL
$25.2 - $28.54 $179,953 - $203,804
-7,141 Reduced 23.43%
23,339 $638,000
Q4 2017

Feb 08, 2018

SELL
$24.79 - $29.8 $65,048 - $78,195
-2,624 Reduced 7.93%
30,480 $756,000
Q3 2017

Nov 08, 2017

SELL
$26.26 - $29.17 $761 - $845
-29 Reduced 0.09%
33,104 $965,000
Q2 2017

Aug 11, 2017

BUY
N/A
33,133
33,133 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.